SlideShare a Scribd company logo
1 of 6
My passion is to acquire, both
                         customer and technical, insight and
                         convert this to commercially
                         successful products.

                         The following slides summarize how
                         I’ve done this for several different
                         markets.

                         Sometimes the key was acquiring
                         insight, sometimes it was improving
                         execution, sometimes it was both.




Niall Sweeney BE, MBA.
Dental market
Changes I implemented which enabled success
 •Redeployed existing technical talent and recruited new talent.
 •Increased rigor of design and timeline management by establishing an effective
 design review process and creating project management roles.
 • Advocated and enabled pilot launches followed by enhancements and scale-up.


Examples of products launched




                                               Midwest® Stylus™ ATC                           THINsert®
 X-Smart®Easy                                  Worlds most powerful air handpiece delivered    Increased ability to remove hard to access
 Improved ergonomics delivered
                                               through automatic pressure control             calculus delivered through tip innovation
 through cordless technology


Impact
 Dentsply Midwest revolutionizes handpiece                        Rated #1 Handpiece Air-
 technology with the Midwest Stylus ATC                                                                           ATC receives “CR CHOICE”
                                                                  Highspeed for 2011                              designation
 Dental Tribune May 2010
                                                                                                                  Clinicians Report
                                                                  Top 50 technology
Midwest® Stylus™ ATC                                              products Nov 2010
This high-speed, air-driven handpiece offers superior                                         X Smart Easy exceeds sales projections and
performance and precision.                                         Top 100 dental             wins corporate award 2011
Inside Dentistry July/August 2011, Volume 7, Issue 7               products July 2010         THINsert® exceeds sales projections
Orthopedic market
Changes I implemented which enabled success

 •Established the practice of engineers directly observing surgical procedures and documenting
 problems observed.
 •Increased rigor of design and preparation of regulatory submissions.
 •Rapid recruitment of talented engineers (doubled group head count in 18 mts.)

Examples of products launched




Oasis                                    AVS Spacer                        Luxor & Mantis                             Xia III
Stryker’s first cervical stabilization   Stryker’s first line of spacers   Stryker’s first minimally invasive systems Significant upgrade of Stryker’s
system                                                                                                                largest spinal implant system


Impact

 •Launched 9 new products which delivered $57mm of revenue in 2005.
 •Created the two fastest growing business segments in Stryker Spine
 •Won 3 annual corporate awards for best new product
Medical information market
Changes I implemented which enabled success
 •Created an ideation process which produced ideas sufficiently defined for customer evaluation.
 •Implemented a variety of market research methodologies which enabled prioritization of ideas.
 • Recruited a small diverse group and utilized outside services to develop products.
 •Established pipeline reviews as a mechanism to accelerate, redirect or kill projects.
 •Partnered with enabling companied and customers on a pilot basis.
Examples of products launched
                                      Test result indicative that patient                                        3 month summary of patient
                                      has a disease which could be
                                      treated with drug therapy                                                  results stratified by standard of
                                                                                                                 care.

                                      Name of patient’s pharmacy
                                      benefit management (PBM)                                                   Comparison of physician’s
                                      company.                                                                   population vs. a broader
                                                                                                                 population e.g. state wide or
                                                                                                                 nation wide.
                                       List of drugs to treat that disease
                                       and how the patients health plan
                                       covers their cost.                                                        Standard of care followed by list of
                                                                                                                 patients which it suggests might
                                       Explanation to physician, why they                                        benefit from drug therapy.
                                       received this, who is sponsoring it
                                       and option to opt out.
 Formulary Message                                                           Population Care
 Providing physicians, patient specific, drug coverage information at the    Providing physicians with a multi-patient view enabling review
 point of prescribing. Thereby, avoiding wasted physician time and           against standards of care and making it easier to spot when
 increasing patient compliance.                                              treatment intervention is appropriate.

Impact
 •Moved internal start up business from being in the “red” to being in the “black”.
 •Launched 3 new products.
 •Secured customer agreement to fund pilot development.
Diabetes market
Changes I implemented which enabled success
 •Restored trust, on development team, within BD organization and between BD and key customer.
 •Established the practice of customer testing early prototypes and addressing problems identified.
 •Engaged all functions and regions in the creation of a multigenerational development plan and the
 execution of that plan.


Examples of products launched


                             Name of patient’s
                             pharmacy benefit
                             management (PBM)
                             company.




 BD Pen Ultra                                                              BD Optimus
 Providing patients with a discreet easy to use means of self injection.   A blood sampling system which was superior (less painful) to
 Providing Lilly a way to significantly differentiate their insulin.       competitive offerings.



Impact
 •BD’s reputation as a device supplier was restored. Lilly resumed purchase of Pens from BD.
 •BD achieved a proprietary & patented blood sampling system, critical to support its entry in the
 glucose monitoring market and which is still selling today.
 •BD’s core pen needle business was successfully protected
Drug delivery market
Changes I implemented which enabled success
•Led the practice of product developers understanding customer needs through direct observation of
healthcare workers as they went about their work.
•Developed a comprehensive assessment of all safety technology resulting in a technology
investment strategy which the corporation executed.
•Led the development of SafetyGlide and pioneered BD’s first application of stage gate methodology
•Launched SafetyGlide ahead of schedule.
Examples of products launched




 BD SafetyGlide™ Needles                         BD SafetyGlide™ Syringe*                        BD Eclipse™ Needles *
 World’s first single handed safety needle       A single handed solution for Insulin, TB, and   A lower cost single handed solution.
                                                 Allergy syringes

Impact
•Contributed significantly to BD’s growing $700MM safety products business (Ref “The no-stick king”
Modern Healthcare/November 27 2000)
•BD achieved a dominant intellectual property position in safety.
• Gold Award, Product Design and Development Magazine, 1998.
• Design Distinction – Industrial Design Magazine, 1997
•Good Design– Chicago Athenaeum Museum , 1997
 *Development initiated by me and executed by other teams

More Related Content

Viewers also liked

Social Media Curation
Social Media CurationSocial Media Curation
Social Media CurationBrian Moritz
 
Sbpagajiguru 111209023917-phpapp02
Sbpagajiguru 111209023917-phpapp02Sbpagajiguru 111209023917-phpapp02
Sbpagajiguru 111209023917-phpapp02Zaidan Jamaludin
 
Standard chartered marketing campign
Standard chartered marketing campignStandard chartered marketing campign
Standard chartered marketing campignXiiangEelyn
 
순천경실련강좌(1)9월26일
순천경실련강좌(1)9월26일순천경실련강좌(1)9월26일
순천경실련강좌(1)9월26일Jong Sung Kim
 
여수인문학강좌(1)10월12일
여수인문학강좌(1)10월12일여수인문학강좌(1)10월12일
여수인문학강좌(1)10월12일Jong Sung Kim
 
Centrate Sensor Analysis in Wastewater
Centrate Sensor Analysis in WastewaterCentrate Sensor Analysis in Wastewater
Centrate Sensor Analysis in WastewaterXylem Inc.
 
Standard chartered proposal presentation
Standard chartered proposal presentationStandard chartered proposal presentation
Standard chartered proposal presentationXiiangEelyn
 

Viewers also liked (12)

1
11
1
 
Social Media Curation
Social Media CurationSocial Media Curation
Social Media Curation
 
Sbpagajiguru 111209023917-phpapp02
Sbpagajiguru 111209023917-phpapp02Sbpagajiguru 111209023917-phpapp02
Sbpagajiguru 111209023917-phpapp02
 
Marlon moreno
Marlon morenoMarlon moreno
Marlon moreno
 
Standard chartered marketing campign
Standard chartered marketing campignStandard chartered marketing campign
Standard chartered marketing campign
 
Guia de cinematica (1)
Guia de cinematica (1)Guia de cinematica (1)
Guia de cinematica (1)
 
Pti presentation
Pti presentationPti presentation
Pti presentation
 
순천경실련강좌(1)9월26일
순천경실련강좌(1)9월26일순천경실련강좌(1)9월26일
순천경실련강좌(1)9월26일
 
여수인문학강좌(1)10월12일
여수인문학강좌(1)10월12일여수인문학강좌(1)10월12일
여수인문학강좌(1)10월12일
 
Centrate Sensor Analysis in Wastewater
Centrate Sensor Analysis in WastewaterCentrate Sensor Analysis in Wastewater
Centrate Sensor Analysis in Wastewater
 
Standard chartered proposal presentation
Standard chartered proposal presentationStandard chartered proposal presentation
Standard chartered proposal presentation
 
Presentation
PresentationPresentation
Presentation
 

Similar to Introducing Niall Sweeney

Commercial considerations in early drug development
Commercial considerations in early drug developmentCommercial considerations in early drug development
Commercial considerations in early drug developmentSunil Ramkali
 
Orlando Agrippa, Draper & Dash at "Journeys of Health-Tech Innovation" Nov 3...
Orlando Agrippa, Draper & Dash  at "Journeys of Health-Tech Innovation" Nov 3...Orlando Agrippa, Draper & Dash  at "Journeys of Health-Tech Innovation" Nov 3...
Orlando Agrippa, Draper & Dash at "Journeys of Health-Tech Innovation" Nov 3...Health-Tech Innovation LABS
 
David Blank Professional Experience 1 PowerPoint
David Blank Professional Experience 1 PowerPointDavid Blank Professional Experience 1 PowerPoint
David Blank Professional Experience 1 PowerPointDavid Blank
 
A Vision for U.S. Healthcare's Radical Makeover
A Vision for U.S. Healthcare's Radical MakeoverA Vision for U.S. Healthcare's Radical Makeover
A Vision for U.S. Healthcare's Radical MakeoverCognizant
 
Pcori challenge hd
Pcori challenge hdPcori challenge hd
Pcori challenge hdhbocian14
 
Life Sciences Implications of the U.S. Affordable Care Act
Life Sciences Implications of the U.S. Affordable Care ActLife Sciences Implications of the U.S. Affordable Care Act
Life Sciences Implications of the U.S. Affordable Care ActCognizant
 
Become a Dragon(r) Medical Practice Edition Partner
Become a Dragon(r) Medical Practice Edition PartnerBecome a Dragon(r) Medical Practice Edition Partner
Become a Dragon(r) Medical Practice Edition Partnergr8situation
 
Top tips to overcome the challenge of commissioning diagnostic services
Top tips to overcome the challenge of commissioning diagnostic services Top tips to overcome the challenge of commissioning diagnostic services
Top tips to overcome the challenge of commissioning diagnostic services NHS Improvement
 
Pharm Mfgr Advise1998
Pharm Mfgr Advise1998Pharm Mfgr Advise1998
Pharm Mfgr Advise1998rogerstrube
 
Understanding Digital Therapeutics: Journey into Imagination
Understanding Digital Therapeutics: Journey into ImaginationUnderstanding Digital Therapeutics: Journey into Imagination
Understanding Digital Therapeutics: Journey into ImaginationEmily Kunka, MS, CCRP
 
Stratified Medicines Innovation Platform
Stratified Medicines Innovation PlatformStratified Medicines Innovation Platform
Stratified Medicines Innovation PlatformEuroBioForum
 
Developing the Dashboard
Developing the DashboardDeveloping the Dashboard
Developing the DashboardJane Chiang
 
Medical Quality Presentation 1998
Medical Quality Presentation 1998Medical Quality Presentation 1998
Medical Quality Presentation 1998rogerstrube
 
Matt Gymer 2012 Innovate Carolina Presentation
Matt Gymer 2012 Innovate Carolina PresentationMatt Gymer 2012 Innovate Carolina Presentation
Matt Gymer 2012 Innovate Carolina Presentationpdmacarolinas
 
Medical devices positioning
Medical devices positioningMedical devices positioning
Medical devices positioningNitesh ..
 

Similar to Introducing Niall Sweeney (20)

Commercial considerations in early drug development
Commercial considerations in early drug developmentCommercial considerations in early drug development
Commercial considerations in early drug development
 
CMAC 2011 Presentation
CMAC 2011 PresentationCMAC 2011 Presentation
CMAC 2011 Presentation
 
Orlando Agrippa, Draper & Dash at "Journeys of Health-Tech Innovation" Nov 3...
Orlando Agrippa, Draper & Dash  at "Journeys of Health-Tech Innovation" Nov 3...Orlando Agrippa, Draper & Dash  at "Journeys of Health-Tech Innovation" Nov 3...
Orlando Agrippa, Draper & Dash at "Journeys of Health-Tech Innovation" Nov 3...
 
David Blank Professional Experience 1 PowerPoint
David Blank Professional Experience 1 PowerPointDavid Blank Professional Experience 1 PowerPoint
David Blank Professional Experience 1 PowerPoint
 
A Vision for U.S. Healthcare's Radical Makeover
A Vision for U.S. Healthcare's Radical MakeoverA Vision for U.S. Healthcare's Radical Makeover
A Vision for U.S. Healthcare's Radical Makeover
 
Pcori challenge hd
Pcori challenge hdPcori challenge hd
Pcori challenge hd
 
Life Sciences Implications of the U.S. Affordable Care Act
Life Sciences Implications of the U.S. Affordable Care ActLife Sciences Implications of the U.S. Affordable Care Act
Life Sciences Implications of the U.S. Affordable Care Act
 
Become a Dragon(r) Medical Practice Edition Partner
Become a Dragon(r) Medical Practice Edition PartnerBecome a Dragon(r) Medical Practice Edition Partner
Become a Dragon(r) Medical Practice Edition Partner
 
Top tips to overcome the challenge of commissioning diagnostic services
Top tips to overcome the challenge of commissioning diagnostic services Top tips to overcome the challenge of commissioning diagnostic services
Top tips to overcome the challenge of commissioning diagnostic services
 
Pharm Mfgr Advise1998
Pharm Mfgr Advise1998Pharm Mfgr Advise1998
Pharm Mfgr Advise1998
 
Understanding Digital Therapeutics: Journey into Imagination
Understanding Digital Therapeutics: Journey into ImaginationUnderstanding Digital Therapeutics: Journey into Imagination
Understanding Digital Therapeutics: Journey into Imagination
 
MEDTECH 2014 Closing Keynote
MEDTECH 2014 Closing KeynoteMEDTECH 2014 Closing Keynote
MEDTECH 2014 Closing Keynote
 
Stratified Medicines Innovation Platform
Stratified Medicines Innovation PlatformStratified Medicines Innovation Platform
Stratified Medicines Innovation Platform
 
Developing the Dashboard
Developing the DashboardDeveloping the Dashboard
Developing the Dashboard
 
Medical Quality Presentation 1998
Medical Quality Presentation 1998Medical Quality Presentation 1998
Medical Quality Presentation 1998
 
Odelle dos
Odelle dosOdelle dos
Odelle dos
 
Matt Gymer 2012 Innovate Carolina Presentation
Matt Gymer 2012 Innovate Carolina PresentationMatt Gymer 2012 Innovate Carolina Presentation
Matt Gymer 2012 Innovate Carolina Presentation
 
Odelle
OdelleOdelle
Odelle
 
Clinbio Overview
Clinbio OverviewClinbio Overview
Clinbio Overview
 
Medical devices positioning
Medical devices positioningMedical devices positioning
Medical devices positioning
 

Introducing Niall Sweeney

  • 1. My passion is to acquire, both customer and technical, insight and convert this to commercially successful products. The following slides summarize how I’ve done this for several different markets. Sometimes the key was acquiring insight, sometimes it was improving execution, sometimes it was both. Niall Sweeney BE, MBA.
  • 2. Dental market Changes I implemented which enabled success •Redeployed existing technical talent and recruited new talent. •Increased rigor of design and timeline management by establishing an effective design review process and creating project management roles. • Advocated and enabled pilot launches followed by enhancements and scale-up. Examples of products launched Midwest® Stylus™ ATC THINsert® X-Smart®Easy Worlds most powerful air handpiece delivered Increased ability to remove hard to access Improved ergonomics delivered through automatic pressure control calculus delivered through tip innovation through cordless technology Impact Dentsply Midwest revolutionizes handpiece Rated #1 Handpiece Air- technology with the Midwest Stylus ATC ATC receives “CR CHOICE” Highspeed for 2011 designation Dental Tribune May 2010 Clinicians Report Top 50 technology Midwest® Stylus™ ATC products Nov 2010 This high-speed, air-driven handpiece offers superior X Smart Easy exceeds sales projections and performance and precision. Top 100 dental wins corporate award 2011 Inside Dentistry July/August 2011, Volume 7, Issue 7 products July 2010 THINsert® exceeds sales projections
  • 3. Orthopedic market Changes I implemented which enabled success •Established the practice of engineers directly observing surgical procedures and documenting problems observed. •Increased rigor of design and preparation of regulatory submissions. •Rapid recruitment of talented engineers (doubled group head count in 18 mts.) Examples of products launched Oasis AVS Spacer Luxor & Mantis Xia III Stryker’s first cervical stabilization Stryker’s first line of spacers Stryker’s first minimally invasive systems Significant upgrade of Stryker’s system largest spinal implant system Impact •Launched 9 new products which delivered $57mm of revenue in 2005. •Created the two fastest growing business segments in Stryker Spine •Won 3 annual corporate awards for best new product
  • 4. Medical information market Changes I implemented which enabled success •Created an ideation process which produced ideas sufficiently defined for customer evaluation. •Implemented a variety of market research methodologies which enabled prioritization of ideas. • Recruited a small diverse group and utilized outside services to develop products. •Established pipeline reviews as a mechanism to accelerate, redirect or kill projects. •Partnered with enabling companied and customers on a pilot basis. Examples of products launched Test result indicative that patient 3 month summary of patient has a disease which could be treated with drug therapy results stratified by standard of care. Name of patient’s pharmacy benefit management (PBM) Comparison of physician’s company. population vs. a broader population e.g. state wide or nation wide. List of drugs to treat that disease and how the patients health plan covers their cost. Standard of care followed by list of patients which it suggests might Explanation to physician, why they benefit from drug therapy. received this, who is sponsoring it and option to opt out. Formulary Message Population Care Providing physicians, patient specific, drug coverage information at the Providing physicians with a multi-patient view enabling review point of prescribing. Thereby, avoiding wasted physician time and against standards of care and making it easier to spot when increasing patient compliance. treatment intervention is appropriate. Impact •Moved internal start up business from being in the “red” to being in the “black”. •Launched 3 new products. •Secured customer agreement to fund pilot development.
  • 5. Diabetes market Changes I implemented which enabled success •Restored trust, on development team, within BD organization and between BD and key customer. •Established the practice of customer testing early prototypes and addressing problems identified. •Engaged all functions and regions in the creation of a multigenerational development plan and the execution of that plan. Examples of products launched Name of patient’s pharmacy benefit management (PBM) company. BD Pen Ultra BD Optimus Providing patients with a discreet easy to use means of self injection. A blood sampling system which was superior (less painful) to Providing Lilly a way to significantly differentiate their insulin. competitive offerings. Impact •BD’s reputation as a device supplier was restored. Lilly resumed purchase of Pens from BD. •BD achieved a proprietary & patented blood sampling system, critical to support its entry in the glucose monitoring market and which is still selling today. •BD’s core pen needle business was successfully protected
  • 6. Drug delivery market Changes I implemented which enabled success •Led the practice of product developers understanding customer needs through direct observation of healthcare workers as they went about their work. •Developed a comprehensive assessment of all safety technology resulting in a technology investment strategy which the corporation executed. •Led the development of SafetyGlide and pioneered BD’s first application of stage gate methodology •Launched SafetyGlide ahead of schedule. Examples of products launched BD SafetyGlide™ Needles BD SafetyGlide™ Syringe* BD Eclipse™ Needles * World’s first single handed safety needle A single handed solution for Insulin, TB, and A lower cost single handed solution. Allergy syringes Impact •Contributed significantly to BD’s growing $700MM safety products business (Ref “The no-stick king” Modern Healthcare/November 27 2000) •BD achieved a dominant intellectual property position in safety. • Gold Award, Product Design and Development Magazine, 1998. • Design Distinction – Industrial Design Magazine, 1997 •Good Design– Chicago Athenaeum Museum , 1997 *Development initiated by me and executed by other teams